- Status:
- Red
- Decision Date:
- December 2020
Comments
RED1: NICE TA659 - prevention of migraine in adults who have ≥ 4 migraine days per month. See local commissioning algorithm for further details.
CCG commissioned
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
search again